Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry
Research output: Contribution to journal › Journal article › Research › peer-review
To evaluate the effect of agalsidase beta on longitudinal health-related quality of life in patients with Fabry disease.
Original language | English |
---|---|
Journal | Journal of Endodontics |
Volume | 12 |
Issue number | 11 |
Pages (from-to) | 703-12 |
Number of pages | 10 |
ISSN | 0099-2399 |
DOIs | |
Publication status | Published - 1 Nov 2010 |
ID: 34197994